Adjuvant Radiotherapy Project
Study aims and objectives
The role of adjuvant radiotherapy in the treatment of resectable pancreatic cancer is controversial and not routinely offered in centres throughout Australia. Although surgery offers the best chance of a cure, a significant proportion of patients who have had surgery develop recurrence of the disease. This raises the question of further post-operative treatment.
The purpose of this study is to review the progress of patients who have had radiotherapy following surgery for resectable disease. It is anticipated that an observed benefit will require a review of current clinical practice.
This study will also develop an important information set to assist the cancer community's knowledge about treatment approaches to pancreatic cancer.
Study Primary Investigator
Dr Chelsie O'Connor completed her medical degree at the University of Newcastle in 2005, followed by internship and residency at Bankstown Hospital in Sydney, NSW. She has a keen interest in cancer research and has been associated with the Pancreatic Cancer Research Group at the Garvan Institute in various capacities over the years.
Dr. O'Connor now divides her time between clinical work as a Radiation Oncology Registrar at Liverpool Hospital in Sydney and pancreatic cancer research at the Garvan Institute. Her key areas of research interest currently lies in the utilisation of radiation treatment for pancreatic cancer, and biomarkers which may predict response to radiation treatment.